Heinrich Roder
Chief Technology Officer at OxCan (Oxford Cancer Analytics)
Steamboat Springs, Colorado, United States
Find your path to Heinrich
143 people in our graph share verified history with Heinrich — schools, employers, funds. One of them is your warm intro.
Alan EzekowitzunlockedHeinrich: together at University of Oxford (1983–1984)
×7Heinrich: together at University of Oxford
×4Heinrich: together at Los Alamos National Laboratory
About
Heinrich Roder is Senior Vice President of R&D at Oxford Cancer Analytics. He has over 20 years of experience leading cross-disciplinary research teams focused on personalized health care and has authored more than 50 peer-reviewed publications on methods and clinical applications. He holds 23 US patents.
Chief Technology Officer at OxCan (Oxford Cancer Analytics)
Intro paths
→
In turn, Heinrich can intro founders to OxCan (Oxford Cancer Analytics)'s investors below.
OxCan (Oxford Cancer Analytics)'s investors · 8
Civilization Ventures Management, LlcTiburon · $1M – $10M checksCross-Border Impact VenturesToronto · $2M – $10M checksDigitalDx VenturesMenlo ParkEka VenturesLondon · $635K – $3.8M checksMeridian Health VenturesLondonOnstageLondonOxford Technology ManagementOxford · $200K – $400K checksUK Innovation & Science Seed FundLondon · $127K – $635K checks
Co-founders at OxCan (Oxford Cancer Analytics)
AH
Andreas HalnerFounder and Head of Healthcare AI
Experience
- Oxford Cancer AnalyticsSVP R&Dcurrent2025 — presentOxfordshire, England, United Kingdom
- Biodesix, Inc.Chief Technology Officer and Founder2000 — 2023
- Los Alamos National LaboratoryStaff Member1994 — 1999Los Alamos County, New Mexico, United States
- University of BayreuthAssistant Professor1989 — 1994Bayreuth, Bavaria, Germany
- Univeristy of HannoverPostdoctoral Scientist1986 — 1989Hannover, Lower Saxony, Germany
Skills & more
Academic ResearchComputer ScienceResearch SkillsTeachingBiotechnologySoftware DevelopmentCancer ResearchPresentation SkillsMolecular BiologyLeadershipOncologyPython (Programming Language)
+11 more
PublicationsTeam LeadershipPresentationsBioinformaticsAlgorithmsData ScienceAssay DevelopmentArtificial Intelligence (AI)ProteomicsDeep LearningBiomarker DevelopmentFrom Heinrich's professional profile.
Frequently asked questions
- Who is Heinrich Roder?
- Heinrich Roder is Senior Vice President of R&D at Oxford Cancer Analytics. He has over 20 years of experience leading cross-disciplinary research teams focused on personalized health care and has authored more than 50 peer-reviewed publications on methods and clinical applications. He holds 23 US patents.
- Where does Heinrich Roder work?
- Heinrich Roder is Chief Technology Officer at OxCan (Oxford Cancer Analytics).
- Where did Heinrich Roder go to school?
- Heinrich Roder studied at University of Oxford (D Phil, Theoretical and Mathematical Physics); University of Erlangen, Erlangen, Germany (Vordiplom, Physics).
Same school
Also attended University of Oxford1,772
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockMichael MoritzFormer Partner at Sequoia Capital; Senior Adviser at Sequoia HeritageGabriel PereyraCo-founder & President of HarveyDominic JacquessonInvestor at Index VenturesErin Price-WrightInvestor at Index VenturesJan HammerInvestor at Index Ventures
+ 1,766 more
Shared employers
Also worked at Oxford Cancer Analytics2
Also worked at Los Alamos National Laboratory59
Lucas HarringtonCo-founder and CSO at SciFoundersPaul ConleyChairman & CEO at GENERAL INCEPTIONPeter LeeManaging Partner at Baroda VenturesBrad MorieSenior Director, Biotechnologies at Research Corporation TechnologiesAlex LuceGeneral Partner at Creative VenturesAndy KonwinskiFounder and General Partner at Laude Ventures
+ 53 more
Also worked at University of Bayreuth7
Beatrix von SchröderVenture Partner at noaJonathanInvestor at Caesar VenturesDr. Janina ZippelSenior Scientist R&D Startup Scouting at Beiersdorf Innovation FundHendrik KayeCofounder at KULT FARMLorenz MuckFounder at NATIXSylvain PetitgirardCo-founder | CSO at Forge Minerals
+ 1 more